Skip to main content

IQVIA s Value Stock - Dividend - Research Selection

IQVIA Holdings

ISIN: US46266C1053, WKN: A2JSPM

Market price date: 23.07.2021
Market price: 249,08 USD




IQVIA Holdings Fundamental data and company key figures of the share

Annual reports in USD
Key figures 26-03-2021
Cash flow
Net operating cash flow 1.959.000.000
Capital Expenditures -616.000.000
Free cash flow 1.343.000.064
Balance sheet
Total Equity 6.001.000.000
Liabilities & Shareholders equity 24.564.000.000
Income statement
Net income 279.000.000
Eps (diluted) 1,430
Diluted shares outstanding 195.000.000
Net sales/revenue 11.359.000.000

Fundamental ratios calculated on: 23-07-2021

Ratios
Key figures 23-07-2021
Cash flow
P/C 24,79
   
P/FC 36,17
Balance sheet
ROI1,14
ROE24,43
Income statement
P/E174,18
Div. Yield0,00%
P/B8,09
P/S4,28


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolIQV
Market Capitalization48.570.601.472,00 USD
Country
IndicesS&P 500
Sectors
Raw Data SourceUS GAAP in Millionen USD
Stock Split
Internetwww.iqvia.com


Description of the company

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.iqvia.com